. "apolipoprotein B; LDL-cholesterol; dyslipidemia; cardiometabolic risk; insulin resistance; metabolic syndrome; apolipoprotein B targets; guidelines"@en . "Objective: To characterize the differences in various risk factors for atherosclerosis between individuals with apoB higher (H) and lower (L) than predicted from regression equation apoB vs LDL-C. Methods: We evaluated 391 dyslipidemic subjects not treated with hypolipidemic drugs. The measured parameters included lipid profile, apolipoproteins A-1 and B, markers of insulin resistance and inflammation/hemostasis. Results: Correlation coefficient between apoB and LDL-C was 0.9 (p<0.0001). Individuals with H apoB compared to L apoB had significantly higher sex and age adjusted BMI, waist circumference, insulin, HOMA (fasting insulinglucose/22,5), C-peptide, proinsulin, PAI-1, sICAM-1, sVCAM-1, t-PA, vWF, frequency of metabolic syndrome and lower values of TD, LDL-C and HDL-C (p<0,05 to <0.001 for all parameters). Conclusion: individuals with apoB higher than predicted by their LDL-C levels are more insulin resistant and have more atherogenic risk profile. Thus, at least for dyslipidemic patient"@en . "0009-9120" . . . "RIV/61989592:15110/09:00009786" . "Luke\u0161, Ji\u0159\u00ED" . "Novotn\u00FD, Dalibor" . "Frohlich, Ji\u0159\u00ED" . "6"^^ . "Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis" . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "Kar\u00E1sek, David" . . "Vaverkov\u00E1, Helena" . . "Objective: To characterize the differences in various risk factors for atherosclerosis between individuals with apoB higher (H) and lower (L) than predicted from regression equation apoB vs LDL-C. Methods: We evaluated 391 dyslipidemic subjects not treated with hypolipidemic drugs. The measured parameters included lipid profile, apolipoproteins A-1 and B, markers of insulin resistance and inflammation/hemostasis. Results: Correlation coefficient between apoB and LDL-C was 0.9 (p<0.0001). Individuals with H apoB compared to L apoB had significantly higher sex and age adjusted BMI, waist circumference, insulin, HOMA (fasting insulinglucose/22,5), C-peptide, proinsulin, PAI-1, sICAM-1, sVCAM-1, t-PA, vWF, frequency of metabolic syndrome and lower values of TD, LDL-C and HDL-C (p<0,05 to <0.001 for all parameters). Conclusion: individuals with apoB higher than predicted by their LDL-C levels are more insulin resistant and have more atherogenic risk profile. Thus, at least for dyslipidemic patient" . "RIV/61989592:15110/09:00009786!RIV10-MZ0-15110___" . . . "Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis"@en . . . "42" . "12" . "Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis" . . . . . . "3"^^ . . . "[F87094A4DFC6]" . "Halenka, Milan" . "Clinical Biochemistry" . . "Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis"@en . "303709" . . . . "15110" . "7"^^ . . . "P(NR9068)" . "Jackuliakov\u00E1, Dagmar" .